Indications and uses
temporarily relieves minor aches and pains due to: headache muscular aches minor pain of arthritis toothache backache the common cold menstrual cramps temporarily reduces fever
temporarily relieves minor aches and pains due to: headache muscular aches minor pain of arthritis toothache backache the common cold menstrual cramps temporarily reduces fever
do not take more than directed the smallest effective dose should be used adults and children 12 years and over take 1 tablet every 4 to 6 hours while symptoms persist if pain or fever does not respond to 1 tablet, 2 tablets may be used do not exceed 6 tablets in 24 hours, unless directed by a doctor Children under 12 years ask a doctor
(in each tablet)
Ibuprofen USP, 200 mg (NSAID)**
**nonsteroidal anti-inflammatory drug
Pain reliever/fever reducer
Allergy alert: Ibuprofen may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include:
If an allergic reaction occurs, stop use and seek medical help right away.
Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you:
Heart attack and stroke warning: NSAIDs, except aspirin, increase the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed.
If pregnant or breast-feeding, ask a health professional before use. It is especially important not to use ibuprofen at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
adults and children |
|
Children under |
|
Brown Tablets: Anhydrous Lactose, Carnauba Wax, Colloidal Silicon Dioxide, Corn Starch, Hypromellose, Iron Oxide Red, Magnesium Stearate, Microcrystalline Cellulose, Polydextrose, Polyethylene Glycol, Povidone, Sodium Lauryl Sulfate, Sodium Starch Glycolate, Titanium Dioxide
Orange Tablets: Anhydrous Lactose, Carnauba Wax, Colloidal Silicon Dioxide, Corn Starch, FD&C Yellow #6, Hypromellose, Magnesium Stearate, Microcrystalline Cellulose, Polydextrose, Polyethylene Glycol, Povidone, Sodium Lauryl Sulfate, Sodium Starch Glycolate, Titanium Dioxide
Call 1-877-835-5472
Monday through Friday 9AM - 5PM EST.
*Amneal Pharmaceuticals is not affiliated with the owner of the trademark Advil®
Distributed By:
Amneal Pharmaceuticals LLC
Bridgewater, NJ 08807
Rev. 10-2022-02
NDC 53746-140-24
Ibuprofen Tablets USP, 200 mg
24 Tablets
Amneal Pharmaceuticals LLC
NDC 53746-143-24
Ibuprofen Tablets USP, 200 mg
24 Tablets
Amneal Pharmaceuticals LLC
| Class | Version | Type | Effective |
|---|---|---|---|
| IBUPROFEN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20191108 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 1e73f975-1ce7-705e-2bcf-788b1b5e24ba | Product name | 5 | 20251124 |
| 16cde546-8deb-4df2-a072-dab5566ede95 | Product name | 1 | 20231003 |
| f6d1b8d7-3bd1-4248-eddd-b60565c88015 | Product name | 4 | 20230808 |
| 874f4e63-49d2-5150-5d77-052172814ebd | Product name | 6 | 20230105 |
| 557673c2-8256-b351-e863-4ec71a5a64b0 | Product name | 2 | 20160714 |
| dbc9a339-6215-4e94-9546-57a3b34902ce | Product name | 1 | 20160517 |
| 61c18d4e-b552-5478-8fc0-df38b93e3100 | Product name | 1 | 20140508 |
| 7b2938c9-7eb7-e312-ae90-f54f4240361e | Product name | 1 | 20140508 |
| 997601aa-bb5f-6971-6b90-a21132c12c7b | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 53746-140-01 | IbuprofenPain Releiver/ Fever Reducer | 100 in 1 BOTTLE | TABLET | 100 | 16 | |
| 53746-140-10 | IbuprofenPain Releiver/ Fever Reducer | 1000 in 1 BOTTLE | TABLET | 1000 | 16 | |
| 53746-140-24 | IbuprofenPain Releiver/ Fever Reducer | 24 in 1 BOTTLE | TABLET | 24 | 16 | |
| 53746-143-01 | IbuprofenPain Releiver/ Fever Reducer | 100 in 1 BOTTLE | TABLET | 100 | 16 | |
| 53746-143-10 | IbuprofenPain Releiver/ Fever Reducer | 1000 in 1 BOTTLE | TABLET | 1000 | 16 | |
| 53746-143-24 | IbuprofenPain Releiver/ Fever Reducer | 24 in 1 BOTTLE | TABLET | 24 | 16 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 53746-140 | IBUPROFEN PAIN RELEIVER/ FEVER REDUCER (IBUPROFEN) TABLET [AMNEAL PHARMACEUTICALS OF NEW YORK LLC] | 16 | Current NDC, Legacy NDC, 3 package rows | 20240101_ee241be0-35f8-4789-a71f-98de31d6a590.zip |
| 53746-143 | IBUPROFEN PAIN RELEIVER/ FEVER REDUCER (IBUPROFEN) TABLET [AMNEAL PHARMACEUTICALS OF NEW YORK LLC] | 16 | Current NDC, Legacy NDC, 3 package rows | 20240101_ee241be0-35f8-4789-a71f-98de31d6a590.zip |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 53746-140-01 | EA - Each | 53746-140 | 9b59909e-f012-4650-b0bb-48b247569696 | 1 | 2013-02-11 |
| 53746-140-10 | EA - Each | 53746-140 | ec68f427-dec6-4174-929c-cfc07f475edc | 1 | 2012-07-24 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| IBUPROFEN | ACTIVE INGREDIENT | WK2XYI10QM | 12 | |
| IBUPROFEN | ACTIVE MOIETY | WK2XYI10QM | 12 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | 12 | |
| CARNAUBA WAX | INACTIVE INGREDIENT | R12CBM0EIZ | 12 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 12 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | 12 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | 12 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | 12 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 12 | |
| POLYDEXTROSE | INACTIVE INGREDIENT | VH2XOU12IE | 12 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | 12 | |
| POVIDONES | INACTIVE INGREDIENT | FZ989GH94E | 12 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 12 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | 12 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | 12 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | 12 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | 12 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 53746-140 | 53746-140-24, 53746-140-01, 53746-140-10 |
| 53746-143 | 53746-143-24, 53746-143-01, 53746-143-10 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET / ORAL | 1127 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | 6184 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET / ORAL | 232 mg | ||
| ANHYDROUS LACTOSE | ANHYDROUS LACTOSE | 3SY5LH9PMK | TABLET / ORAL | 6795 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET / ORAL | 232 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | 6184 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET / ORAL | 8 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET / ORAL | 8 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET / ORAL | 232 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET / ORAL | 1127 mg | ||
| POVIDONES | POVIDONE | FZ989GH94E | TABLET / ORAL | 216 mg | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | TABLET / ORAL | 167.8 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET / ORAL | 1127 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | 6184 mg | ||
| ANHYDROUS LACTOSE | ANHYDROUS LACTOSE | 3SY5LH9PMK | TABLET / ORAL | 6795 mg | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | TABLET / ORAL | 167.8 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET / ORAL | 232 mg | ||
| ANHYDROUS LACTOSE | ANHYDROUS LACTOSE | 3SY5LH9PMK | TABLET / ORAL | 6795 mg | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | TABLET / ORAL | 60.02 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | TABLET / ORAL | 233 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET / ORAL | 1127 mg | ||
| POLYDEXTROSE | POLYDEXTROSE | VH2XOU12IE | TABLET / ORAL | 20 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| POLYDEXTROSE | POLYDEXTROSE | VH2XOU12IE | TABLET / ORAL | 20 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET / ORAL | 8 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | TABLET / ORAL | 233 mg | ||
| POVIDONES | POVIDONE | FZ989GH94E | TABLET / ORAL | 216 mg | ||
| POLYDEXTROSE | POLYDEXTROSE | VH2XOU12IE | TABLET / ORAL | 20 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / ORAL | 750 mg | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | TABLET / ORAL | 167.8 mg | ||
| POLYDEXTROSE | POLYDEXTROSE | VH2XOU12IE | TABLET / ORAL | 20 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET / ORAL | 232 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | 6184 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | TABLET / ORAL | 167.8 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / ORAL | 750 mg | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | TABLET / ORAL | 60.02 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | TABLET / ORAL | 233 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / ORAL | 750 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET / ORAL | 1127 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET / ORAL | 232 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | 6184 mg | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | TABLET / ORAL | 60.02 mg | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | TABLET / ORAL | 167.8 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET / ORAL | 8 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / ORAL | 750 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| ANHYDROUS LACTOSE | ANHYDROUS LACTOSE | 3SY5LH9PMK | TABLET / ORAL | 6795 mg | ||
| POLYDEXTROSE | POLYDEXTROSE | VH2XOU12IE | TABLET / ORAL | 20 mg | ||
| ANHYDROUS LACTOSE | ANHYDROUS LACTOSE | 3SY5LH9PMK | TABLET / ORAL | 6795 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | TABLET / ORAL | 233 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / ORAL | 750 mg | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | TABLET / ORAL | 60.02 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A071333-001 | IBUPROFEN | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A071333-001 | IBUPROFEN | 200MG | TABLET / ORAL | 1987-02-17 | f41ea6bd6efb… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ibuprofen Pain Releiver/ Fever Reducer | IBUPROFEN | Amneal Pharmaceuticals of New York LLC | ee241be0-35f8-4789-a71f-98de31d6a590 | 2023-12-31 | Warnings | 53746-140-01 53746-143-10 53746-140-10 53746-140-24 53746-143-24 53746-143-01 53746-143 53746-140 53746014301 53746014310 53746014001 53746014024 53746014010 53746014324 e2b9bf54-0449-4f9b-86e8-e3b292387dd5 ee241be0-35f8-4789-a71f-98de31d6a590 |
Adverse event summaries are temporarily unavailable. Other product information remains available.